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Abstract
Background: Multifactorial diseases arise from complex patterns of interaction between a set of genetic traits and
the environment. To fully capture the genetic biomarkers that jointly explain the heritability component of a
disease, thus, all SNPs from a genome-wide association study should be analyzed simultaneously.
Results: In this paper, we present Bag of Naïve Bayes (BoNB), an algorithm for genetic biomarker selection and
subjects classification from the simultaneous analysis of genome-wide SNP data. BoNB is based on the Naïve Bayes
classification framework, enriched by three main features: bootstrap aggregating of an ensemble of Naïve Bayes
classifiers, a novel strategy for ranking and selecting the attributes used by each classifier in the ensemble and a
permutation-based procedure for selecting significant biomarkers, based on their marginal utility in the
classification process. BoNB is tested on the Wellcome Trust Case-Control study on Type 1 Diabetes and its
performance is compared with the ones of both a standard Naïve Bayes algorithm and HyperLASSO, a penalized
logistic regression algorithm from the state-of-the-art in simultaneous genome-wide data analysis.
Conclusions: The significantly higher classification accuracy obtained by BoNB, together with the significance of
the biomarkers identified from the Type 1 Diabetes dataset, prove the effectiveness of BoNB as an algorithm for
both classification and biomarker selection from genome-wide SNP data.
Availability: Source code of the BoNB algorithm is released under the GNU General Public Licence and is available
at http://www.dei.unipd.it/~sambofra/bonb.html.
Background
In the past few years, the hereditary component of com-
plex multifactorial diseases has started to be explored
through the novel paradigm of Genome-Wide Association
Studies (GWASs). A GWAS searches for patterns of
genetic variation, in the form of Single Nucleotide Poly-
morphisms (SNPs), between a population of affected indi-
viduals (cases) and a healthy population (controls). The
objective of a GWAS is twofold: on the one hand, one
searches for the set of SNPs that best explains the heredi-
tary component of the disease (genetic biomarkers); on
the other hand, one tries to learn a rule for classifying
unknown subjects as cases or controls, given their genetic
profile and possibly other environmental covariates [1].
Further applications of GWASs include searching for
the genetic predisposition to complex traits, such as height
[2] or Body Mass Index [3], or to the responsiveness to a
treatment in a randomized trial [4]. The application of
GWAS is not limited to human: successful results have
been obtained by applying the GWAS framework to ani-
mal [5] and plant research [6].
The extremely large numbers involved in a GWAS
(millions of SNPs measured for thousands of individuals)
have led the vast majority of studies to rely upon single,
univariate SNP association tests [7-9]. Multifactorial dis-
eases, however, have an heterogeneous nature, arising
from complex patterns of interaction between a set of
genetic traits and the environment: to fully capture the
optimal set of genetic biomarkers, thus, all SNPs in a
GWAS should be analyzed simultaneously in a multivari-
ate framework [10].
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In the literature, the few approaches to multivariate
SNP analysis on a genome-wide scale mainly rely on
two methodological frameworks: penalized logistic
regression [10-12] and Bayesian analysis [13]. In the first
case, SNPs are modelled as discrete variables from the
finite domain {0,1,2} (where 0 usually encodes the
homozygous pair of minor alleles, 1 the heterozygous
pair and 2 the homozygous pair of major alleles) and a
log-additive model of genetic effect on the disease is
assumed. In the second case, SNPs are modelled as tern-
ary categorical variables and no assumptions are usually
made on pre-specified genetic models.
All methods for the simultaneous analysis of the
whole SNP set have to cope with genetic linkage, i.e. the
non random association between portions of the gen-
ome close to each other, which acts as a confounding
factor: in the proximity of a true causal genetic biomar-
ker, several SNPs highly correlated with the biomarker
but mildly associated to the disease are often observed
[14].
In this work, we present Bag of Naïve Bayes (BoNB),
an algorithm for classification and genetic biomarker
selection from the simultaneous analysis of genome-
wide SNP data. Our algorithm is based on Naïve Bayes
(NB) classification [15], thus it relies on contingency
table analysis and it does not assume a pre-specified
model of genetic effect.
Three strategies are exploited in BoNB to tailor the
Naïve Bayes framework to genome-wide SNP data ana-
lysis: (a) a bagging of Naïve Bayes classifiers, to improve
the robustness of the predictions, (b) a novel strategy
for ranking and selecting the attributes used by each
bagged classifier, to enforce attribute independence, and
(c) a permutation-based procedure for selecting signifi-
cant biomarkers, based on their marginal utility in the
classification process.
BoNB is tested on the WTCCC case-control study on
Type 1 Diabetes [7]. In terms of classification perfor-
mance, assessed through repeated random sub-sampling
cross validation and measured with the Matthews Cor-
relation Coefficient [16], BoNB outperforms both a stan-
dard Naïve Bayes classifier, trained on the SNPs that
reached genome-wide significance in a univariate test,
and HyperLASSO, a state-of-the-art penalized logistic
regression technique specifically designed for the simul-
taneous analysis of genome-wide data [10].
Results
Algorithm
Given a dataset X, consisting of n observations (sub-
jects) of p attributes (SNPs), and a set Y of class labels,
one for each observation (case/control), a Naïve Bayes
Classifier (NBC, [15]) estimates from the dataset a clas-
sification rule in the form:





iPr(Xi|Y = yj) , (1)
where Y is the random variable representing the class
label and X1 . . . Xp are the random variables represent-
ing the p attributes.
The classification rule of Equation (1) states that the
probability of a subject being in class yk, given a combi-
nation of values for the attributes X1 . . . Xp, is equal to
the a priori probability of class yk, Pr(Y = yk), times the
probability of each attribute given class yk, Pr(Xi|Y = yk):
the implicit assumption below this classification rule is
that attributes X1 . . . Xp are all conditionally indepen-
dent given Y.
For categorical attributes, such as SNPs, probability
distributions Pr(Y = yk) and Pr(Xi|Y = yk) are repre-
sented with conditional probability tables, which are
estimated from the data by counting the occurrences of
each combination of genotypes and class labels (see
Methods for more details).
Our algorithm, Bag of Naïve Bayes (BoNB), consists in
an ensemble of Naïve Bayes Classifiers, trained on
GWAS data with the procedure known as Bootstrap
Aggregating or Bagging [17].
Given a training dataset X, the Bagging procedure
starts by computing a set of B Bootstrap replicates of X,
i.e. a set {X(1) . . . X(B)} of datasets, each one obtained by
sampling n observations with replacement from the
training set X [18]. A Naïve Bayes Classifier NBC(b) is
then trained on each Bootstrap sample X(b). Class prob-
abilities of unseen subjects, drawn from an independent
test set, are then obtained by averaging the output class
probabilities computed by each NBC(b) (Figure 1). Such
an approach is known to increase the robustness of the
predictions [17].
Given the binary nature of the case/control classifica-
tion problem and the frequent unbalance between the
number of cases and controls in a GWAS, we decided
to rely on the Matthews Correlation Coefficient (MCC,
[16]) for assessing classification performance. The MCC
is defined as:
MCC =
tp · tn − fp ·fn√
(tp + fp)·(tp + fn)·(tn + fp)·(tn + fn) , (2)
where tp, tn, fp and fn stand for true positives, true
negatives, false positives and false negatives, respectively.
The MCC is often preferred to standard classification
accuracy, i.e. to the proportion of correctly classified
examples, because it is not sensitive to class unbalance:
the MCC, in fact, ranges from -1 (all examples incor-
rectly classified) to 1 (all correctly classified) and equals
0 in case of majority classification, i.e. when all labels
are assigned to the most represented class.
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The conditional independence assumption below the
Naïve Bayes classification rule (Equation (1)) is unlikely
to hold if all the SNPs of a GWAS are exploited as attri-
butes, because of genetic linkage. Moreover, computing
Equation (1) for the whole SNP set can be computation-
ally cumbersome and can lead to numerical and overfit-
ting problems.
We thus developed a procedure for selecting a good
set of independent SNPs for each NBC(b): the procedure
consists of a ranking step followed by an attribute selec-
tion step. In the ranking step, each SNP is given a score,
according to its ability in discriminating the subjects in
the bootstrap sample X(b). The score is thus defined as
the MCC of a Naïve Bayes Classifier, trained and tested
on the same set X(b), with the SNP as a single attribute
(a precise mathematical description of the Naïve Bayes
attribute score is given in Methods). SNPs are then
ranked in decreasing order of score.
In the attribute selection step, SNPs are iteratively
extracted from the top of the ranked list and added as
attributes of NBC(b). Each time a SNP is included as an
attribute, the procedure removes from the ranked list all
the SNPs that are both close to the SNP on the genome
(distance < 1 Mb) and correlated with it (r2 >θ, where r2
is the squared correlation between the two SNPs and θ
is a user defined threshold, default = 0.1). Such an
approach enforces attribute independence, thus coping
with the problems arising from genetic linkage.
Rather than including one SNP at a time, uncorrelated
SNPs are added in groups of exponentially increasing
size, starting from one SNP and doubling the size at
each new addition. New SNPs are added as long as the
generalization ability of NBC(b) increases: to estimate
the generalization ability, we test each NBC(b) on the
corresponding Out-of-Bag sample OOB(b), consisting of
all the observations left out from X when sampling X(b),
and measure the MCC of the prediction. The exponen-
tial increase in the number of added attributes allows
BoNB to reach the adequate size for the attribute set of
each NBC in a logarithmic number of steps.
The attribute selection procedure, iterated for the B
bootstrap samples, results in an ensemble of B Naïve
Bayes Classifiers, each with a possibly different set of
attributes. Classification of unseen subjects, the first
objective of GWASs, is then obtained by averaging the
output class probabilities across all NBCs. Classification
performance of the ensemble of NBCs can then be
assessed on an independent GWAS test set, by measur-
ing the MCC of the predictions.
For the second objective of GWASs, biomarker selec-
tion, we adapted for BoNB a procedure originally
designed for the Random Forests bagged classifier [19]:
for each of the SNPs included as attributes by at least 5%
of the NBCs, we randomly permute the genotype of the
SNP in the OOB sets, test each NBC(b) on its correspond-
ing OOB(b) and record the relative decrease in MCC due
to the permutation. Such a measure, which we define
marginal utility (MU), can be used as an indicator of the
importance of each selected attribute, given all other
selected attributes.
For each SNP, the permutation procedure returns a
list of values of MU, one value for each NBC that
included the SNP: we test for MUs significantly greater
than zero with a one-tailed Wilcoxon signed rank test,
Figure 1 Schematics of the BoNB algorithm: B Bootstrap samples {X(1) . . . X(B)} are drawn from a GWAS training dataset X; B Naïve Bayes
Classifiers (NBC) are trained on the Bootstrap samples, with the novel procedure for attribute ranking and selection; predictions of unseen
subjects from a GWAS test dataset are carried out independently by each NBC and class probabilities are then averaged; biomarker selection is
carried out with the novel permutation-based procedure, exploiting Out-of-Bag (OOB) samples.
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selecting as biomarkers the SNPs for which the p-value
of the test is lower than 0.05.
The following pseudocode summarizes the training
phase and the biomarker selection phase of the BoNB
algorithm:
BoNB(X, Y, B, θ)
// Training
1 for b = 1 to B
2 [X(b), OOB(b)] = bootstrap replicate from X
3 for s = 1 to p
4 Compute the contingency table for SNP s from X(b)
5 Compute the Naïve Bayes attribute score of s
6 L(b) = list of SNPs in decreasing order of score
7 Initialize NBC(b) as a Naïve Bayes Classifier with
no attributes
8 Extract M = 1 new attributes for NBC(b) from the
top of L(b), excluding from future additions all SNPs at
distance > 1 Mb and with r2 <θ
9 while MCC of NBC(b), tested on OOB(b) with the
new attributes, increases
10 Add the new attributes to NBC(b)
11 Update M = 2 * M
12 Extract M new attributes from the top of L,
excluding each time from future additions all SNPs at
distance > 1 Mb and with r2 <θ
// Biomarker selection
13 for s in all SNPs selected by at least 5% of the
NBCs
14 for b in all NBCs that selected s
15 Permute the genotype of s in OOB(b)
16 Record the Marginal Utility (MU) of s
17 Select as biomarkers the SNPs with MU signifi-
cantly larger than zero.
For analyzing the computational complexity of BoNB,
one can start by noting that, for each b in B, the attribute
ranking step (lines 3-6) has complexity O(np) for comput-
ing the contingency tables and the scores (where n is the
number of subjects and p is the number of SNPs in the
dataset) plus O(p log p) for sorting the score list, thus has
a total complexity of O[Bpn + Bp log p)].
The attribute selection step (lines 7-12), executed for
each b in B, has a computational complexity dominated
by two operations: computation of the squared correla-
tion coefficient r2 between SNPs and test of NBC(b) on
OOB(b). If we define M the average number of attri-
butes included by each NBC (which is problem depen-
dent) and p¯1Mb the average number of SNPs in a 1 Mb
section of the DNA (which is dataset dependent, but is
a roughly linear function of p), we can note that the
first operation costs O(n) for each SNP pair and is
executed M · p¯1Mb times, having thus a total computa-
tional complexity of O(BnM¯ p¯1Mb) . The second opera-
tion, on the other hand, is executed log M¯ + 2 times,
each time with a doubling number of features for NBC
(b), and its computational complexity is thus expressed
by the following summation:
log M¯+1∑
i=0
n¯OOB · 2i = n¯OOB(2log M¯+2 − 1) ∼= O(nM¯),
where n¯OOB is the average number of subjects in an
OOB set, tending to (1 - 1/e) · n for large n [18]; the total
complexity of the second operation is thus O(BnM¯) ,
asymptotically negligible with respect to the cost of com-
puting the squared correlation coefficients. The total com-
putational complexity of the training phase of the BoNB
algorithm is thus O[B(pn + p log p + nM¯p¯1Mb)] .
For the complexity of the biomarker selection phase of
BoNB, we define p¯5% the number of SNPs selected by at
least 5% of NBCs (which is problem dependent) and note
that the inner loop of lines 15-16 is executed at most
O(Bp¯5%) times; since the cost of the two operations in
the loop is linear in n, the biomarker selection phase has
a total computational complexity of O(Bnp¯5%) .
Testing
BoNB was tested on the WTCCC case-control study on
Type 1 Diabetes [7]: the study examined approximately
2000 T1D cases and 3000 healthy controls. Each subject
was genotyped on the Affymetrix GeneChip 500K Map-
ping Array Set.
We excluded a small number of subjects according to
the sample exclusion lists provided by the WTCCC. In
addition, we excluded a SNP if (i) it is on the SNP
exclusion list provided by the WTCCC; (ii) it has a poor
cluster plot as defined by the WTCCC. The resulting
dataset consists of 458376 SNPs, measured for 1963
cases and 2938 controls.
The number B of Bootstrap replicates used by BoNB
was set to 200 and the threshold θ on r2 for uncorre-
lated SNPs was set to 0.1. Please see Methods for an
analysis of how performance is affected by variations of
the parameters B and θ.
Independent train-test set pairs for assessing the clas-
sification performance of BoNB were obtained by
repeatedly sub-sampling at random 90% of the dataset
for training and 10% for testing. The procedure was iter-
ated 10 times and classification performance was
assessed with the MCC of the predictions on the test
sets. The list of selected biomarkers, on the other hand,
was computed on the whole dataset.
Classification performance was compared with the
ones obtained by a standard Naïve Bayes Classifier,
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trained on all the SNPs that reached the significance
threshold of 5 × 10-7 (as in [7]) in a single 2df c2 test of
association with a general genetic model, and by Hyper-
LASSO, a logistic regression method for the simulta-
neous analysis of all SNPs in a genome-wide association
study [10]. The former algorithm was chosen to assess
the improvement of BoNB both in terms of biomarker
selection, with respect to a standard univariate test, and
in terms of classification performance, with respect to
the algorithm on which BoNB is based. The latter algo-
rithm was chosen because of its best performance
among classification and biomarker selection methods
for genome-wide data, as reported in [10] and [20], and
because of the complete availability of the source code
(see Methods for further details on the Naïve Bayes and
HyperLASSO algorithms).
On the experimental dataset, BoNB reached an MCC
of 0.55 ± 0.03 (mean ± standard deviation), significantly
higher than the ones reached by both the standard
Naïve Bayes Classifier (0.31 ± 0.05, Wilcoxon signed-
rank p-value 0.002) and by HyperLASSO (0.46 ± 0.03,
p-value 0.002). Figure 2 (left panel) shows the boxplots
of the MCC obtained by the three algorithms on the ten
iterations of the sub-sampling procedure. For the sake
of completeness, Figure 2 (right panel) shows also the
boxplots of classification accuracy. The dashed lines in
the two plots represent the classification performance of
a majority classifier.
To further analyze the behaviour of the three methods
at different levels of the output function (i.e. of the out-
put class probability for BoNB and the standard Naïve
Bayes classifier and of the logistic regression value for
HyperLASSO) we report in Figure 3 the Precision vs
Recall curve and the Receiver Operating Characteristic,
or True Positive Rate vs True Negative Rate curve, of
the three algorithms on one of the ten random subsam-
plings (the behaviour on the other subsamplings is simi-
lar). As it is clear from the figure, the performance of
the standard Naïve Bayes classifier is completely domi-
nated by the performance of both BoNB and Hyper-
LASSO. Concerning the two latter algorithms, one can
observe that HyperLASSO has a better performance at
the two extremities of the curves, i.e. for subjects whose
logistic regression value is closer to the maximum or
the minimum; moving from the extremities to the mid-
dle scores, BoNB outperforms HyperLASSO, being
indeed able to reach overall higher MCC and classifica-
tion accuracy.
For biomarker selection, we run BoNB on the whole
dataset and compared its results with the biomarkers
identified by HyperLASSO and by the general 2df test.
The average number of attributes included by BoNB in
each NBC was 3.24, 75 SNPs were included by at least
one NBC and 9 SNPs by at least 5% of the NBCs (see
Table 1). Among the 9 SNPs, only 7 SNPs reached the
significance level on the permutation test and were cho-
sen as genetic biomarkers (marked in bold in Table 1).
All the 7 selected SNPs fall into regions of interest for
Type 1 Diabetes according to the on-line database
T1DBase [21] (cytobands p13.2 on chromosome 1 and
p21.32 on chromosome 6, also known as the MHC
region) and their association with the disease was con-
firmed in a larger meta-analysis, subsequent to the
WTCCC study [9]. The squared correlation coefficients
Figure 2 Box plots of MCC (left panel) and classification accuracy (right panel) of the standard Naïve Bayes classifier, HyperLASSO and
BoNB on ten random subsamplings of the WTCCC T1D dataset. The dashed lines represent the classification performance of a majority
classifier.
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between all pairs of selected SNPs are all lower than
0.155, indicating low redundancy in the information
coded by the set of 7 SNPs.
Compared to the 394 SNPs that reached the signifi-
cance level on the 2df general test, both the list of 75
SNPs used for classification and the list of 7 biomarkers
selected by BoNB are more compact, but this does not
prevent BoNB to reach significantly higher classification
performance.
HyperLASSO selected 8 SNPs, all in the MHC region
of chromosome 6: 4 of the SNPs are among the biomar-
kers selected by BoNB, thus suggesting a certain coher-
ence between the two algorithms and providing further
confidence on the identified biomarkers.
Implementation
BoNB is implemented in C++ and relies only on stan-
dard libraries, thus being fully portable across operating
systems. On the WTCCC case-control study on Type 1
Diabetes, BoNB takes approximately 50 minutes for
training 200 NBCs and selecting the biomarkers on a
3.00 GHz Intel Xeon Processor E5450. A careful alloca-
tion strategy makes BoNB occupy around 600 MB of
RAM for the WTCCC dataset, allowing it to be easily
run on a desktop computer.
Discussion
In this paper, we presented a novel algorithm for classifica-
tion and biomarker selection from genome-wide SNP data.
The algorithm, Bag of Naïve Bayes (BoNB), is based on the
Naïve Bayes classification framework, enriched by three
main features: bootstrap aggregating of an ensemble of
Naïve Bayes classifiers, a novel strategy for ranking and
selecting the attributes used by each classifier and a permu-
tation-based procedure for selecting significant biomarkers,
based on their marginal utility in the classification process.
The effectiveness of BoNB was demonstrated by apply-
ing it to the WTCCC case-control study on Type 1 Dia-
betes: BoNB indeed outperforms two algorithms from
the state of the art, namely a Naïve Bayes Classifier and
HyperLASSO, in terms of classification performance and
all the genetic biomarkers identified by BoNB are mean-
ingful for Type 1 Diabetes.
Learning an ensemble of classifiers from a bootstrap
sample of the original dataset provides BoNB with two
main advantages: on the one hand, it guarantees a higher
generalization ability by increasing the stability of the
learning process [17]; on the other hand, it allows to
define a measure of the marginal utility of each SNP,
Figure 3 Precision vs Recall curve (left panel) and Receiver Operating Characteristic (right panel) of the standard Naïve Bayes
classifier, HyperLASSO and BoNB on a random subsampling of the WTCCC T1D dataset.
Table 1 SNPs selected as attributes for at least 5% of the
Naïve Bayes Classifiers by BoNB on the WTCCC T1D
dataset, with B = 200 Bootstrap samples and classifiers.




rs6679677 1 RSBN1 downstream 7 0.033
rs9266774 6 MICA upstream 5.5 0.011
rs805301 6 BAT3 intron 17.5 0.043
rs492899 6 SKIV2L intron 8.5 0.025
rs9273363 6 HLA-DQB1 downstream 100 0.835
rs9275418 6 HLA-DQB1 upstream 80 0.160
rs6936863 6 HLA-DQA2 upstream 8 0.08
rs9784858 6 TAP2 intron 5 0.008
rs3101942 6 LOC100294145 exon 21.5 0.045
First column: dbSNP RS ID. Second column: SNP chromosome. Third and
fourth column: annotated gene and relation with the SNP. Fifth column:
percentage of Naïve Bayes Classifiers that included the SNP as attribute. Sixth
column: median of the marginal utility of the SNP. SNPs selected as genetic
biomarkers by the permutation procedure are marked in bold.
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given all the other SNPs exploited for classification, and
to select significant biomarkers among these SNPs in a
sound and statistically principled way.
Two features of the Naïve Bayes Classifier, chosen as
building block of the BoNB algorithm, make it rather
appealing for genome-wide data analysis: on the one
hand, conditional probability table analysis does not
assume a pre-specified model of genetic effect, on the
other hand, missing values are seamlessly handled by
both the learning and the classification procedure.
The idea of bagging Naïve Bayes classifiers has already
been proposed in the Random Naïve Bayes algorithm of
Prinzie and Van der Poel [22]. The authors suggest, as a
means for enforcing independence between the attri-
butes of each NBC, to sample the attributes at random
from the whole attribute set. Such an approach, how-
ever, is unfit to genome-wide data analysis: the number
of informative attributes is largely lower than the total
number of attributes and the probability of capturing
them by random sampling is thus extremely low.
Our approach to attribute selection, consisting in a
univariate ranking step followed by a multivariate selec-
tion step, has the advantage of favouring informative
attributes, but without the need of pre-selecting fixed
sets of attributes or of defining cut-offs on the strength
of the association with the disease: attributes, in fact, are
added to the classifiers as long as their combined effect
on the generalization ability increases.
To provide the reader with further insight on the Naïve
Bayes attribute score, exploited in BoNB for univariate
attribute ranking, we studied it against the 2df c2 statistic
of association for all the SNPs in the Wellcome Trust
Case-Control Study on Type 1 Diabetes (Figure 4).
As it can be seen from the figure, the two measures
are in a strong monotonic relation for the majority of
SNPs; when used as ranking criteria, thus, they are
deemed to return similar ranked lists.
Major exceptions are the points plotted along the two
axes of Figure 4. Along the vertical axis lie the SNPs for
which the c2 test can not be run, because at least one of
the entries in the SNP contingency table has less than 5
elements. Along the horizontal axis, on the other hand,
lie the SNPs that, when used to train a Naïve Bayes
Classifier, lead to a majority classifier, i.e. a classifier
that always returns the most frequent of the two classes
as output: this happens when one of the classes is the
most represented for all the three genotypes of a SNP.
Analyzing the extreme behaviours of the two scoring
measures provides the key for understanding the main
difference between them: while c2 is designed to capture
a difference in SNP frequencies from the frequencies
expected under no association between the SNP and the
disease, the Naïve Bayes attribute score is meant to
select good predictors of the disease, under the Naïve
Bayes classification model.
For this reason, the Naïve Bayes attribute score is not
much sensitive to small variations of contingency table
entries with few or zero elements and thus it does not
require a minimum number of elements per entry. On
the other hand, it does not reward SNPs with even large
differences in frequencies from the case of no association,
if one of the two classes is consistently over represented,
since such SNPs can not be effective as univariate predic-
tors in the dataset under analysis.
Conclusion
The analysis of genome-wide SNP data for multifactorial
diseases mainly suffers from two, intertwined problems:
on the one hand, multifactorial diseases are caused by
complex patterns of interaction between multiple genetic
traits and the environment, on the other hand, genetic
linkage confounds the search for genetic biomarkers,
because of the non-random association between the true
genetic causes and the SNPs in genomic regions close to
them. The algorithm we proposed, Bag of Naïve Bayes,
proved effective in tackling both of these problems: the
simultaneous analysis of all SNPs on a genome-wide scale
can capture the sets of SNPs with the strongest joint effect
on the disease; the novel procedure for attribute ranking
and selection enforces attributes independence, thus dis-
criminating causal SNPs from nearby weaker signals.
Apart from genome-wide association studies, BoNB
can also be applied, with minor modifications, to the ana-
lysis of SNP data from case/control exome sequencing
experiments [23,24]: in this scenario, given the lower
average distance between SNPs on the same genes and
the consequently stronger effect of genetic linkage, the
ability of BoNB to enforce attribute independence would
prove even more useful.
Figure 4 Naïve Bayes attribute score vs c2 statistic for all SNPs
in the WTCCC T1D dataset.
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Methods
Naïve Bayes Algorithm
The Naïve Bayes Algorithm [15] for discrete-valued
inputs and binary classification learns the probability
distributions of Equation 1 estimating two sets of para-
meters. The first is:
θijk = Pr(Xi = xij|Y = yk) 
# D{Xi = xij ∧ Y = yk} + l
# D{Y = yk} + lJ , j = 1 . . . J (3)
for each input attribute Xi, each of its possible values
xij (J = 3 in case of SNPs) and each of the two possible
values yk of Y. The #D {x} operator returns the number
of elements in the training set D that satisfy property x.
In addition, the algorithm must estimate the para-
meters of the prior probability over Y:
πk = Pr(Y = yk)  # D{Y = yk} + l|D| + 2l (4)
where |D| denotes the number of elements in the
training set D.
The only tunable parameter of the Naïve Bayes Algo-
rithm is the l term, known in the Bayesian literature as
Equivalent Sample Size or Dirichlet Weight. Both for
the ensemble of classifiers exploited by the BoNB algo-
rithm and for the standard Naïve Bayes algorithm used
in the comparison l was fixed to 1, implementing what
is called a Laplace smoothing [15].
Naïve Bayes attribute score
In the BoNB algorithm, SNPs are ranked as candidate
attributes of the b-th Naïve Bayes Classifier according to
their ability in discriminating the subjects in the Boot-
strap replicate X(b); this is estimated for each SNP as the
MCC of a Naïve Bayes Classifier, trained and tested on
X(b), with the SNP as the single attribute. The rationale
for such a measure is to give a higher rank to SNPs that
guarantee a lower training error on X(b) when used as
attributes.
For a more formal definition of the score, we start by
defining the elements of the contingency table for the
SNP as in Table 2. Considering that the parameters of a
Naïve Bayes Classifier are estimated according to Equa-
tions (3) and (4) (presented in the previous section) and
that we set the Dirichlet Weight l to 1, we can define
the three following inequalities:






· nco + 1
n + 2
I1 : b + 1
nca + 3





· nco + 1
n + 2
I2 : c + 1
nca + 3





· nco + 1
n + 2
and the three corresponding indicator functions I0, I1
and I2, returning 1 if the inequality holds and 0 other-
wise. The three inequalities determine the behaviour of
the Naïve Bayes Classifier in classifying unseen subjects
according to their genotype, by comparing the posterior
probabilities of the two classes.
When the same set X(b) is used both for training and
for testing, the Naïve Bayes attribute score S can be com-
puted as the MCC of the prediction from Equation (2):
S =
(ae − bd)(I0 − I1) + (af − cd)(I0 − I2) + (bf − ce)(I1 − I2)√
ncanco · [n0n1 · XOR(I0, I1) + n0n2 · XOR(I0, I2) + n1n2 · XOR(I1, I2)]
, (5)
where XOR (·,·) is the boolean operator returning 1 if
exactly one of the operands is equal to 1, and 0
otherwise.
HyperLASSO algorithm
The HyperLASSO algorithm [10] is a Bayesian-inspired
penalized logistic regression approach exploiting a NEG
prior for the attribute weights. The NEG prior is a con-
tinuous prior distribution with a sharp mode at zero,
which has the effect of shrinking the regression weights
heavily when they are near zero. The NEG prior has a
shape parameter, which we set to the default value 0.1.
Like all other penalized logistic regression approaches,
the HyperLASSO algorithm has a tunable parameter l
controlling the relative weight of the model complexity
(i.e. of the number of SNPs included in the classifier)
versus the model likelihood. We tested several values of
l, namely 50, 100, 250 and 500, and chose the one lead-
ing to the best classification performance on the
WTCCC T1D dataset (l = 250).
The HyperLASSO algorithm has an element of sto-
chasticity, namely in the order with which model para-
meters are updated in the model selection procedure,
and is designed to carry out multiple runs with different
orderings and report the best scoring model. For our
analysis, we set the number of runs to 10, resulting in
approximately 60 hours for processing the entire
WTCCC T1D dataset on a 3.00 GHz Intel Xeon Proces-
sor E5450.
Table 2 Contingency table of a SNP, with the genotype
codes 0 for the homozygous pair of minor alleles, 1 for
the heterozygous pair and 2 for the homozygous pair of
major alleles.
genotype 0 1 2
cases a b c nca
controls d e f nco
n0 n1 n2 n
Each element in the contingency table reports the number of subjects with
the corresponding genotype and phenotype. n0, n1 and n2 are the column
sums, nca and nco are the row sums and n is the total subject count for the
SNP.
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Effect of parameters variation on the performance of
BoNB
The BoNB algorithm exposes two parameters to the
user: the number of Bootstrap replicates and Naïve
Bayes Classifiers, B, and the threshold on the squared
correlation coefficient above which two SNPs are con-
sidered correlated, θ.
Figure 5, left panel, represents the MCC obtained by
BoNB on ten random subsamplings of the WTCCC
T1D dataset, for B = 200 and θ ranging from 0.02 to
0.5. As it is clear from the figure, θ = 0.1 is optimal and
results in a significantly higher classification perfor-
mance (Kruskal-Wallis test p-value 3.7 × 10-4).
Concerning the number of Bootstrap replicates B, on
the other hand, one can observe from Figure 5, right
panel, that classification performance is not much sensi-
tive to variations of B (Kruskal-Wallis test p-value 0.98),
though it is slightly higher for B = 50 and 200. Analyz-
ing the list of selected biomarkers, BoNB returns the
same seven biomarkers reported in Table 1 for B = 200
and 500, adds SNP rs2856688 to the list for B = 100
and misses SNPs rs6679677 and rs492899 for B = 50.
Given the consistency among the results for higher
values of B, suggested values for BoNB parameters are
thus θ = 0.1 and B = 200.
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